The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Size and Charge Adaptive Clustered Nanoparticles Targeting the Biofilm Microenvironment for Chronic Lung Infection Management
Abstract
Abstract Chronic lung infection caused by bacterial biofilms is an extremely serious clinical problem, which can lead to the failure of antibiotic therapy. Although nanoparticles have shown great potential in the treatment of biofilms, the efficient penetration and retention of nanoparticles in biofilms is still a big challenge. To address this issue, we herein fabricate size and charge adaptive azithromycin (AZM)-conjugated clustered nanoparticles (denoted as AZM-DA NPs) as therapeutic agents for treating biofilms. The AZM-DA NPs are prepared by electrostatic complexation between AZM conjugated amino-ended poly(amidoamine) dendrimer (PAMAM) and 2,3-dimethyl maleic anhydride (DA) modified poly(ethylene glycol)-block-polylysine (PEG-b-PLys). It is noteworthy that the AZM-DA NPs can disassemble in an acidic biofilm microenvironment (pH 6.0), leading to the release of secondary AZM-conjugated PAMAM nanoparticles (PAMAM-AZM NPs). PAMAM-AZM NPs with small size and positive charge are beneficial for improved penetration and retention inside biofilms, enhanced permeabilization of the bacterial membrane, and increased internalization of AZM, thus exhibiting excellent antibiofilm activities. AZM-DA NPs are also favorable as long-term antibacterial agents due to the reduced occurrence of drug resistance. In vivo therapeutic performance is confirmed by the reduced bacterial burden and the alleviated inflammation in the chronic lung infection model. This research not only develops an innovative strategy for antibiotic delivery in vivo but also provides an effective way for the management of biofilm-associated infections, including chronic lung infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Xiao, F., Cao, B., Wang, C., Guo, X., Li, M., Xing, D., & Hu, X. (2019) · ACS Nano · doi:10.1021/acsnano.8b07251 · Cited by 117
RetractedBacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Biofilms: an emergent form of bacterial life
Flemming, H.-C., Wingender, J., Szewzyk, U., Steinberg, P., Rice, S. A., & Kjelleberg, S. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.94 · Cited by 5,979
Antibiotic resistance of bacteria in biofilms
Stewart, P. S., & William Costerton, J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05321-1 · Cited by 4,585
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
Nanotechnology as a therapeutic tool to combat microbial resistance
Pelgrift, R. Y., & Friedman, A. J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.011 · Cited by 1,432
Pseudomonas aeruginosa: all roads lead to resistance
Breidenstein, E. B. M., de la Fuente-Núñez, C., & Hancock, R. E. W. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.04.005 · Cited by 1,286
Du, J.-Z., Du, X.-J., Mao, C.-Q., & Wang, J. (2011) · Journal of the American Chemical Society · doi:10.1021/ja207150n · Cited by 1,172
Self-citationBeceiro, A., Tomás, M., & Bou, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-12 · Cited by 1,070
Pseudomonas Aeruginosa: Resistance to the Max
Poole, K. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00065 · Cited by 948
Pseudomonas syringae: what it takes to be a pathogen
Xin, X.-F., Kvitko, B., & He, S. Y. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2018.17 · Cited by 780
Nanotechnology-based antimicrobials and delivery systems for biofilm-infection control
Liu, Y., Shi, L., Su, L., van der Mei, H. C., Jutte, P. C., Ren, Y., & Busscher, H. J. (2019) · Chemical Society Reviews · doi:10.1039/c7cs00807d · Cited by 737
Ciofu, O., & Tolker-Nielsen, T. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00913 · Cited by 720
Hu, D., Li, H., Wang, B., Ye, Z., Lei, W., Jia, F., Jin, Q., Ren, K.-F., & Ji, J. (2017) · ACS Nano · doi:10.1021/acsnano.7b04731 · Cited by 565
Self-citationApplying insights from biofilm biology to drug development — can a new approach be developed?
Bjarnsholt, T., Ciofu, O., Molin, S., Givskov, M., & Høiby, N. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4000 · Cited by 516
Hu, D., Deng, Y., Jia, F., Jin, Q., & Ji, J. (2020) · ACS Nano · doi:10.1021/acsnano.9b05493 · Cited by 489
Self-citationPrevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment
Valerius, N. H., Koch, C., & Høiby, N. (1991) · The Lancet · doi:10.1016/0140-6736(91)91446-2 · Cited by 475
El-Sawy, H. S., Al-Abd, A. M., Ahmed, T. A., El-Say, K. M., & Torchilin, V. P. (2018) · ACS Nano · doi:10.1021/acsnano.8b06104 · Cited by 431
Diffusion of Nanoparticles in a Biofilm
Peulen, T.-O., & Wilkinson, K. J. (2011) · Environmental Science & Technology · doi:10.1021/es103450g · Cited by 419
Liu, Y., Busscher, H. J., Zhao, B., Li, Y., Zhang, Z., van der Mei, H. C., Ren, Y., & Shi, L. (2016) · ACS Nano · doi:10.1021/acsnano.6b01370 · Cited by 379
Meers, P., Neville, M., Malinin, V., Scotto, A. W., Sardaryan, G., Kurumunda, R., Mackinson, C., James, G., Fisher, S., & Perkins, W. R. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn059 · Cited by 345
Tumor Acidity-Sensitive Polymeric Vector for Active Targeted siRNA Delivery
Sun, C.-Y., Shen, S., Xu, C.-F., Li, H.-J., Liu, Y., Cao, Z.-T., Yang, X.-Z., Xia, J.-X., & Wang, J. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b09602 · Cited by 343
Self-citationNalca, Y., Jänsch, L., Bredenbruch, F., Geffers, R., Buer, J., & Häussler, S. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.5.1680-1688.2006 · Cited by 317
Ciofu, O., Tolker-Nielsen, T., Jensen, P. Ø., Wang, H., & Høiby, N. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.11.017 · Cited by 306
Du, J.-Z., Li, H.-J., & Wang, J. (2018) · Accounts of Chemical Research · doi:10.1021/acs.accounts.8b00195 · Cited by 276
Self-citationZhang, Y., Sun, P., Zhang, L., Wang, Z., Wang, F., Dong, K., Liu, Z., Ren, J., & Qu, X. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201808594 · Cited by 273
Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis
Parkins, M. D., Somayaji, R., & Waters, V. J. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-18 · Cited by 253
Deng, Q., Sun, P., Zhang, L., Liu, Z., Wang, H., Ren, J., & Qu, X. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201903018 · Cited by 251
Nanoparticles for Oral Biofilm Treatments
Benoit, D. S. W., Sims, K. R., & Fraser, D. (2019) · ACS Nano · doi:10.1021/acsnano.9b02816 · Cited by 231
Han, H., Hou, Y., Chen, X., Zhang, P., Kang, M., Jin, Q., Ji, J., & Gao, M. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c00650 · Cited by 231
Self-citationRational Design of Cancer Nanomedicine for Simultaneous Stealth Surface and Enhanced Cellular Uptake
Jin, Q., Deng, Y., Chen, X., & Ji, J. (2019) · ACS Nano · doi:10.1021/acsnano.8b07746 · Cited by 219
Self-citationBiofilm-Associated Infections: Antibiotic Resistance and Novel Therapeutic Strategies
Sun, F., Qu, F., Ling, Y., Mao, P., Xia, P., Chen, H., & Zhou, D. (2013) · Future Microbiology · doi:10.2217/fmb.13.58 · Cited by 212
Xi, Y., Wang, Y., Gao, J., Xiao, Y., & Du, J. (2019) · ACS Nano · doi:10.1021/acsnano.9b03237 · Cited by 204
Charge-Switchable Nanozymes for Bioorthogonal Imaging of Biofilm-Associated Infections
Gupta, A., Das, R., Yesilbag Tonga, G., Mizuhara, T., & Rotello, V. M. (2018) · ACS Nano · doi:10.1021/acsnano.7b07496 · Cited by 194
Novel Mouse Model of Chronic Pseudomonas aeruginosa Lung Infection Mimicking Cystic Fibrosis
Hoffmann, N., Rasmussen, T. B., Jensen, P., Stub, C., Hentzer, M., Molin, S., Ciofu, O., Givskov, M., Johansen, H. K., & Høiby, N. (2005) · Infection and Immunity · doi:10.1128/iai.73.4.2504-2514.2005 · Cited by 181
Gupta, A., Landis, R. F., Li, C.-H., Schnurr, M., Das, R., Lee, Y.-W., Yazdani, M., Liu, Y., Kozlova, A., & Rotello, V. M. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b06961 · Cited by 173
Silver-Decorated Polymeric Micelles Combined with Curcumin for Enhanced Antibacterial Activity
Huang, F., Gao, Y., Zhang, Y., Cheng, T., Ou, H., Yang, L., Liu, J., Shi, L., & Liu, J. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b03347 · Cited by 169
Self-citationSantos, R. S., Figueiredo, C., Azevedo, N. F., Braeckmans, K., & Smedt, S. C. D. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.12.010 · Cited by 163
Mohammadi, G., Valizadeh, H., Barzegar-Jalali, M., Lotfipour, F., Adibkia, K., Milani, M., Azhdarzadeh, M., Kiafar, F., & Nokhodchi, A. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2010.05.027 · Cited by 161
Strategies to overcome the polycation dilemma in drug delivery
Bernkop‐Schnürch, A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.017 · Cited by 155
Bosnar, M., Kelnerić, Ž., Kos, V. M., Haber, V. E., & Parnham, M. J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2372-2377.2005 · Cited by 152
Targeted delivery of antibiotics to intracellular chlamydial infections using PLGA nanoparticles
Toti, U. S., Guru, B. R., Hali, M., McPharlin, C. M., Wykes, S. M., Panyam, J., & Whittum-Hudson, J. A. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.038 · Cited by 143
Landis, R. F., Li, C., Gupta, A., Lee, Y.-W., Yazdani, M., Ngernyuang, N., Altinbasak, I., Mansoor, S., Khichi, M. A. S., Sanyal, A., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b03575 · Cited by 141
Liu, Y., van der Mei, H. C., Zhao, B., Zhai, Y. W., Cheng, T., Li, Y., Zhang, Z., Busscher, H. J., Ren, Y., & Shi, L. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201701974 · Cited by 139
Murine models of acute and chronic lung infection with cystic fibrosis pathogens
Bragonzi, A. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.08.012 · Cited by 122
Forier, K., Messiaen, A.-S., Raemdonck, K., Nelis, H. J. C. F., Smedt, S. C. D., Demeester, J., Coenye, T., & Braeckmans, K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.061 · Cited by 117
Liu, Y., Ren, Y., Li, Y., Su, L., Zhang, Y., Huang, F., Liu, J., Liu, J., van Kooten, T. G., An, Y., et al. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.08.038 · Cited by 110
Buyck, J. M., Plésiat, P., Traore, H., Vanderbist, F., Tulkens, P. M., & Françoise Van Bambeke, A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis473 · Cited by 107
Wan, F., Bohr, S. S.-R., Kłodzińska, S. N., Jumaa, H., Huang, Z., Nylander, T., Thygesen, M. B., Sørensen, K. K., Jensen, K. J., Sternberg, C., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b19644 · Cited by 90
A charge-adaptive nanosystem for prolonged and enhanced in vivo antibiotic delivery
Chu, L., Gao, H., Cheng, T., et al. (2016) · Chemical Communications · doi:10.1039/c6cc01269h · Cited by 81
Mayer-Hamblett, N., Kloster, M., Rosenfeld, M., Gibson, R. L., Retsch‐Bogart, G. Z., Emerson, J., Thompson, V., & Ramsey, B. W. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ377 · Cited by 78
Emerging nanomedicines for anti-stromal therapy against desmoplastic tumors
Han, X., Xu, Y., Geranpayehvaghei, M., Anderson, G. J., Li, Y., & Nie, G. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119745 · Cited by 76
Zhang, Y., Li, H., Wang, Q., Hao, X., Li, H., Sun, H., Han, L., Zhang, Z., Zou, Q., & Sun, X. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201802675 · Cited by 71
Wang, Q., Mi, G., Hickey, D. J., Li, Y., Tu, J., Webster, T. J., & Shen, Y. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.01.022 · Cited by 61
Moser, C. E., van Gennip, M., Bjarnsholt, T., Jensen, P. Ø., Lee, B., Hougen, H. P., Calum, H., Ciofu, O., Givskov, M., Molin, S., et al. (2009) · Apmis · doi:10.1111/j.1600-0463.2008.00018.x · Cited by 49
pH-Sensitive nanoparticles as smart carriers for selective intracellular drug delivery to tumor
Li, X.-X., Chen, J., Shen, J., Zhuang, R., Zhang, S., Zhu, Z.-Y., & Ma, J. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.05.012 · Cited by 41
Self-citationpH-Sensitive Polymers as Dynamic Mediators of Barriers to Nucleic Acid Delivery
Peeler, D. J., Sellers, D. L., & Pun, S. H. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00695 · Cited by 30
Dynamically crosslinked polymer nanocomposites to treat multidrug-resistant bacterial biofilms
Zhu, D. Y., Landis, R. F., Li, C., Gupta, A., Wang, L., Geng, Y., Gopalakrishnan, S., Guo, J., & Rotello, V. M. (2018) · Nanoscale · doi:10.1039/c8nr06348f · Cited by 26
Fast Biofilm Penetration and Anti-PAO1 Activity of Nebulized Azithromycin in Nanoarchaeosomes
Altube, M. J., Martínez, M. M. B., Malheiros, B., Maffía, P. C., Barbosa, L. R. S., Morilla, M. J., & Romero, E. L. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00721 · Cited by 22
Cited by
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Self-citationUnderstanding bacterial biofilms: From definition to treatment strategies
Zhao, A., Sun, J., & Liu, Y. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1137947 · Cited by 743
Dendrimer-based drug delivery systems: history, challenges, and latest developments
Wang, J., Li, B., Qiu, L., Qiao, X., & Yang, H. (2022) · Journal of Biological Engineering · doi:10.1186/s13036-022-00298-5 · Cited by 406
Self-citationA comprehensive review on various techniques used for synthesizing nanoparticles
Kumari, S., Raturi, S., Kulshrestha, S., Chauhan, K., Dhingra, S., András, K., Thu, K., Khargotra, R., & Singh, T. (2023) · Journal of Materials Research and Technology · doi:10.1016/j.jmrt.2023.09.291 · Cited by 388
Design, optimization, and nanotechnology of antimicrobial peptides: From exploration to applications
Tan, P., Fu, H., & Ma, X. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101229 · Cited by 351
Metadata
- Authors
- Gao, Y., Wang, J., Chai, M., Li, X., Deng, Y., Jin, Q., & Ji, J.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-04-22
- Volume
- 14
- Issue
- 5
- Pages
- 5686-5699
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W3017144105
- Cited by
- 305
- References
- 59
- FWCI
- 10.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.